Wieacker-Wolff syndrome

Wieacker-Wolff syndrome (also known as contractures of the feet, muscle atrophy, and oculomotor apraxia) is an extremely rare X-linked neurological disorder characterized by progressive contractures, muscle wasting, and impaired eye movements. The condition was first described by Wieacker and Wolff in 1985 in affected males of a single family. The syndrome primarily affects the neuromuscular and central nervous systems. Key clinical features include congenital or early-onset contractures of the feet (talipes equinovarus or clubfoot), progressive muscle atrophy predominantly affecting the distal limbs, oculomotor apraxia (difficulty initiating voluntary eye movements), and progressive dysarthria (impaired speech articulation). Affected individuals may also develop facial weakness and intellectual disability of variable severity. The condition is caused by mutations in the ZC4H2 gene located on the X chromosome, which plays a role in neuronal development. There is currently no cure or disease-specific treatment for Wieacker-Wolff syndrome. Management is supportive and symptomatic, focusing on orthopedic interventions for contractures, physical therapy to maintain mobility and function, speech therapy for dysarthria, and occupational therapy. Monitoring by a multidisciplinary team including neurologists, orthopedic specialists, and rehabilitation professionals is recommended. Female carriers may occasionally show mild features of the condition.

Common questions about Wieacker-Wolff syndrome